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We conclude that early aPTT measurements do not reliably reflect hrombin 
inhibition following thrombelysls with tPA and adjunctive ant(coagulation. 
ACUTE MYOCARDIAL  INFARCTION/UNSTABLE 
ANGINA 
~ Cardiac Two-Year Mortal ib/Related to Initial Specific 
Post.Thrombolytic F low Grade 
Kann S. Coyne, Pamela L. Walker, Jonathan S, Ralnar, Yasmine C. Dreoui, 
Cynthia A. Fink, Conor F. Lundergan, Allan M. Ross. George Washington 
University, Washington, DC 
Large clinical myocardial infarction trials with Iong-tarm feflow-up generally 
report late all-cause mortality. In a two year follow-up study of the GUSTO-1 
Angiographio cohort, we sought to relate early (90 minute) post-MI coro- 
nap/patancy to 2-year sundval. Uniquely, however, we have specific cause 
of death (as determined by death certificate, autopsy report, or hospital 
summary) obtained for 92.9% of all patients who died between the index 
hospitalization and two years and who had a 90 minute TIMI flow grade 
assessment (n = 127). Cardiac causes were defined as acute myocardial in- 
farction, congestive heart failure, and sudden deatWanhythmia. Differences 
in cause are displayed according tO 90 minute TIMI flow grade status. 
All.Cause Cardiac Cause Non-Cardiac 
TIMI O, 1 54/347 (15.6%) 44 (12.7%) 10 (2.9%) 
TIMI 2 4PJ305 (13.8%) 34 (11.1%) 8 (2.6%) 
TIMI 3 31/394 (7.9%)* 17 (4.3%)* 14 (3.6°/.) 
°T3 vs. T0,1. 2, p < 0.001 
TIM) 3 flOW results in a 48"/0 reduction in all-cause 2-year mortality while a 
64% reduction is demonstrated with cardiac specific 2.year mortality. 
Conclusion: in post-MI patients, successful immediate treatment (TIMI 3 
flow) leads to dramatic decreases in Iong-tarm all.cause and cardiac deaths. 
All-cause mortality reduction due to an open vessel may underestimate the 
true treatment effect due to existence of non-cardiac deaths. 
~ Influence of  Age and on the Prior Infarction Clinical 
Characteristics o f  Patients With Nbn.Q-Wave 
Myocardial Infarction 
Avanindra Jaln, Robert A. O'Rourke, William E. Beden, for the VANQWISH 
Investigators. Univ. TX. Hlth. Sci. Cntr., San Antonio, TX 
VA Non-Q-Wave Infarction Strategies in-Hospital (VANQWISH) is a prospec- 
tive randomized study to compare conservative strategy (radionuclide van- 
tricutography and exercise thallium) vs invasive strategy (cardiac catheteri- 
zation) in patients with non-Q-wave myocardial infarction (MI), To determine 
whether elderly patients or those with pdor MI have clinical features associ- 
ated with high dsk for cardiac events, we assessed baseline findings in 751 
patients with non-Q-wave MI. 
Age # lots EF High Risk Ti ETT+ LM/3VCAD 
<70 574 50% 27% 24% 42% 
>70 177 48% 41% 28°/. 55% 
p value NS 0.02 NS 0.01 
Ejection fraction - El =. High risk thallium (Ti) - multlzone ischemia or thallium lung uptake. 
ETT+ = positive xercise treadmill test. LM = left main, CAD = coronary artery disease. 
Patient.'3 with a prior MI had a significantly higher incidence of therapy with as- 
pidn (67%), nitrates (53%), beta-blockers (36%), and calcium blockers (52%). 
Prior MI #pts EF High Risk TI ETT+ LM/3VCAD 
Yes 326 47% 35% 27% 60% 
No 425 55% 27% 23% 33% 
p value 0.04 0.09 NS 0.01 
Accordingly, both older non-Q-wave MI patients and those with a prior MI have 
clinical findings indicating an increased dsk for subsequent cardiac events. 
~ Prognostic Signif icance of  ST Segment Monitor ing 
Early After Myocardial  Infarction: GUSTO ECG 
Substudy 
Anatefy Langar, Mitchell W. Krucof, Peter Klootwijk, Chdstopher Granger, 
Maarten Simoons, Paul W. Armstrong. St. Michael's Hospital, Toronto, ON, 
Canada; Duke Universi~ Durham, NC 
The GUSTO ECG Substudy enrolled 1,071 lOtS to provide a non-invasive 
assessment of the speed and stability of reparfusion. We studied 783 pts in 
whom ST segment analysis (> 18 hrs) was feasible (no signifiCant difference 
in baseline charactedstica from 288 pts excluded because of technical fas- 
tots) with respect to 30 day and I year mortality. ST segment shift (ST+) was 
defined as _> 1 mm ST$ from a 24 hr average baseline, measured at J + 60 
me and lasting > 1 roin. STt was measured similarly, but was restricted to 
beyond first 6 hrs from throrobelysis to allow adequate and stable resolution 
of initial STt. 
There were 414 pts (53%) with ST+ (186 pte had only ST,I,) who did not 
differ significantly from 369 ST - pts with respect to baseline characteds- 
tics. No difference in ST shift was seen between four different hrembolytic 
regimens. 
30 Day Mortality 1 Year Mortality 
ST- (n = 369) 1,9% 5,2% 
ST+ (n: 414) 6.0% ° 9.'~,o* 
°p <0.001 vs ST- 
ST segment shift (as a continuous variable) was an independent prediCtor 
of mortality when added to GUSTO mortality model. 
Conclusion: Detection of ST segment shift (ST? and STJ.) is a non-invasive 
marker of poor prognosis and may be incorporated in the early risk stratifica- 
tion of pts requidng further and more aggressive management. Lack of ST 
shift identifies low dsk population for whom cady discharge might be feasible. 
ACUTE MYOCARDIAL  INFARCTION/UNSTABLE 
ANGINA-  LONG TERM OUTCOME 
i 901-- '~ Growth Hormone Attenuates LV Remodel ing and 
Improves Cardiac Function in Rats With Large 
Myocardial  Infarction 
Antonio Cittadini, Jess(ca D. Grossman, Sarah E. Katz, James P. Morgan, 
Pamela S. Douglas. Beth Israel Hospital, Harvard Med. Sc,, Boston, MA 
To evaluate whether early Growth Hormone (GH) treatment improves cardiac 
remodeling and function after myocardial infarction (MI), we studied 32 male 
rats with sham surgery (n = 10) or MI induced by left coronary ligation. The day 
after surgery, the infarcted rats were randomized to receive 3 wk treatment 
with GH 3 mg/kg/day (MI-GH, n = 11) or placebo (MI, n = 11). Transthoracic 
echocardiography, LV catheterization and histology were obtained at 3 wk. 
Data are mean 4- SEM. 
LVRIW EDD/BW FS +dP/dt EDP 
Sham 2.42 :b 0.1 2.4 ~- 0.1 44 4- 2 7900 4" 340 3 ± 0.2 
MI 4.68±0.3" &5 :E0.2* 194-3' 3000±120" 244-2" 
MI-GH 3.60 :l: 0.2 .t' 2.8 4- 0.1 ,,1" 28 4- 2 *t 5500 =l: 140 *T 10 ± 2"t" 
*p < 0.05 vs sham; tp < 0.05 vs MI; BW = body weight (g); EDD = end-dicstolic d{men- 
sion (ram); FS = fractionalshortenlng (%);+dP/dt (mmHg/s); EDP = end.dic~Iolicpressure 
(mmHg). 
Average infarct size was 48 4- 4% in MI-GH and 47 4- 3% in MI. Although 
the increase in LV mass post MI was attenuated by GH, significant cellular hy- 
pertrophy was demonstrated by morphometdc histology in the non-infarcted 
tissue; call diameter in MI-GH group was 9.6 4- 0.3 p.m compared to both MI 
and sham groups (7.7 4- 0.2 and 7.5 ± 0.2 p.m, respectively; both p 4- 0.05 
vs MI-GH), while percent of fibrosis remained unchanged. 
Conclusions: 1. Compared to sham, MI rats exhibited LV dilatation, reduced 
FS and +dP/dt, and increased LV to BW ratio and EDR 2, GH treatment re- 
suited in less LV cavity dilatation and LV/BW despite increased royocyte 
size, and in the improvement of all indexes of cardiac function, These data 
demonstrate that eady GH treatment after large MI dramatically attenu- 
ates LV pathologic remodeling and improves systolic and diastolic function. 
GH-induced hypertrophy of non-infarcted myocytas may contdbute to these 
beneficial effects. 
[ ~ l s  Smoking Really Protective In Acute MI? 
Richard Davies, Helen Johansen, Murray Kaiserman, Jean Rouleau, 
Pierre Savarcl, Bruce Sussex, Martin Gardner, Claude Lauzon, 
Robert Dupuis, Duncan Stewart, Marlo Talajic, Wayne Warn(ca, Kathy Fods, 
Etel Mikes for the CAMI Investigators, Bureau of Tobacx~ Control, Ottawa 
Background: Current smokers have been reported to have a better post-MI 
prognosis than non-smokers. Four of the six articles found that smoking was 
stiU significantly associated with better survival after adjusting for age and 
other risk factors. We address this in a sequential sedes of 3,821 MI patients 
aged < 76 admitted to eight Canadian hospitals between July 1, 1990 ane 
December 30, 1992. 
Methods: Logistic models were constructed using different strategies tc 
correct for age, gender, disease ssvedty indices and dsk factors. 
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Results: Current smokers were younger than never smokers (age '= 54 vs 
61 yrs for men, 58 vs 66 yrs for women, ps ~ 0.001). The average age at 
death for smokers and non-smokers was rosp~:ctively 58 and 64 for men (P 
< 0.01), and 64 and 67 for women (p = NS). Non smoking men had more 
pre-existing high blood pressure, diabetes, and high cholesterol evels, while 
non-smoking women had more diabetes. In models of in-hospital mortality 
using 2 age groups and no gender variable, the adjusted odds ratio for 
smokers was 0.61 (p < 0.001). A model including 6 age groups and gender 
yielded an odds ratio of 0.80 (p = NS). Separate models for men and women 
yielded odds ratios of 0.76 and 0.87 (p = NS). 
Conclusions. The previously reported protective ffect of smoking is largely 
a statistical artefact. Post-MI mortality for smokers is not significan W different 
from non-smokers, and their average age at death is lower, especially arn~ng 
men. 
ADULT CARDIOTHORACIC  SURGERY 
~ Does Blood Flow Through Transmyocardlal CO2 
Laser Channels? 
Takushi Kohmoto, Peter E. Fisher, Anguo Gu, Shu-Miog Zhu, Craig 
R. Smith, Daniel Burkhoff. Columbia University, New York, NY 
Preliminary reports suggest that transmyocardial laser revasculatization 
(TMLR) is effective in relieving angina in patients who are unresponsive 
to conventional therapies. However, expedmsntal evidence of nutritive blood 
flow through the TMLR channels is not available. To test whether blood could 
flow through the channels created with the CO2 laser (800 W, 40 J/pulse), 
an average of 12 channels/heart (~ l/cm 2) were created over the distal LAD 
territory of 5 canine hearts. The heart was then arrested with a cardioplegio 
solution and excised. The aortic valve was surgically closed to prevent LV 
ejection. The right and left cOronary arteries were cannulated and perfusion 
to the Isolated heart was re-established with cross circulation from a second 
dog. A cannuta connected to a reservoir and inserted into the LV was used 
to control the LV filling and aftedcad pressures. The LAD and the epicar- 
dial collaterals were ligeted to make the channel region ischemic. Collateral 
flow to the chaanet region, measured by colored microspheres injected into 
the coronary ertedee, was 6.8 4- 4.2% of the control region (0.11 4- 0.07 
mVg/min vs. 1.66 + 0.88 ml/g/min). Colored microspheres were then injected 
into the LV chamber. LV loading was adjusted to achieve peak LV pressure 
generation of 20 mmHg (low loading) and 120 mmHg (high loading). There 
was no significant difference between the numbers of spheres per gram of 
myocardium in the LCX region (control area without channels) and in the 
LAD channel region as shown in the table. 
Low loading High loading 
LCX/control 272 4.162 347 4. 299 
LAD/channel (epicardium) 183 4-146 443 =t: 286 
LAD/channel (endocardium) 308 4. 281 514 4. 290 
Thus, the blood inside the LV chamber did not perfuse the myocardium 
through the TMLR channels in this acute ischemic model. Blood flow through 
the channels may not be the mechanism of the clinical benefit of this proce- 
dure. 
~ Exclmer Laser Channels Protect Against 
Myocardia l  Ischemls 
Peter Whittaker, Robert A. KIoner. Heart Institute, Good Sarnadtan Hospital 
& University of Southern California, Los Angeles, CA 
We sought to determine whether transmural channels made using an excimer 
laser could protect against coronary artery occlusion (CAO). We tested the 
hypothesis by making 3 channels in the left ventricle (LV) of rat hearts 
using a 600 micron diameter fiber, a pulse energy of 9 mJ and e repe~on 
rate of 20 Hz; parameters that produced wide channels with limited thermal 
injury in vitro. We challenged channel-mediated protection (65-120 days 
later) by subjecting hearts to 90 rain of CAO. We used histology to divide 
treated heads into 2 groups; those with and those without 2 or more open 
channels. Necrosis (N), calculated as a percent of beth the LV and the area 
at risk (AR), was compared to that in controls also subjected to 90 rain 
CAO. In addition, we measured the width of tibrosis associated with each 
channel. 
# N/LV (%) N/AR (%) Rbrosis (~.m) 
Controls 10 27 4. 3 59:1= 3
< 2 channels 5 32 -4- 4 66 4. 2 280 4. 40 
> 2 channels 5 17 4- 2* 46 -;- 4 A 170 4. 2(]* 
*p < 0.05 vs. control 
The presence of open channels connected to the LV cavity reduced necro- 
sis, but closed channels did not. Open channels also had less fibrosis, and 
we obsen/ed blood vessels connecting with these laser channels. We pro- 
pose that the degree of initial thermal injury, manifest by fibrosis, determines 
long-term channel palency and hence the degree of proteCtion against CAO. 
Furthermore, we speculate that protection is provided by blood flow to the 
tiSsue from the LV cavity via the channels. We conclude that, in instances 
of minimal fibrosis, excimer.mede transmural channels can protect against 
myocardial ischemia. 
ANGIOPLASTY-  CONVENTIONAL 
~ Volume-Mortality Tradeoff for Pereutaneous 
Trsnsluminal Coronary  Angioplasty in the United 
States 
Norman S. Kato, Grace M. Carter. UCLA Medical Center, Los Angeles, CA; 
RAND, Santa Monica, CA 
Minimum annual percutanoous transluminal coronary angioplasty (PTCA) 
volume of 200 per hospital has been recommended to improve quality. PTCA 
outcomes until 1990 have shown a slight volume-mortality radeoff. We tested 
the hypothesis that the volume-mortality tradesff was time dependent. We 
examined the Health Cam Financing Administi'ation 1991 Mortality Informa- 
tion Database on 862 hospitals performing 113,576 procedures. We found 
no statistically significant linear correlation between PTCA volume and risk- 
adjusted procedure mortality (RAPM) (r 2 = 0.0002; p = 0.67). We then plotted 
RAPM versus arbitrary Medicare PTCA volume cutoffs at 50, 100, 150, 200, 
250, and 300. RAPM was recalculated by pooling data for all programs 
falling below and above these cutoff points. The difference between these 
two groups ranged from 0.08% to 0.19%. There was a statistically significant 
difference between all groups above and below these cutoffs; however except 
for PTCA volume < 50, all lower volume programs had lower mortality than 
higher volume programs at each volume cutoff (p < 0.0001). We conclude: 
1) there is no linear correlation between PTCA procedure volume and mor- 
tality for the Medicare population in 1991; 2) the differences between RAPM 
among programs above and below arbibary volume cutoffs are small and do 
not always favor the higher volume programs; 3) establishment of minimum 
volume requirements may increase the incentive for the inappropriate use of 
PTCA by marginal programs. 
~ Operator and Institutional Volume O0 Not Affect 
the Procedural Outcome of  Primary Angioplasty 
Therapy 
William W. O'Neill, John J. Griffin, Gregg Stone, Bruce Brodie, Denise 
E. Jones, Dedra Sachs. Paolo Esente, Michael Spain, Mike Ayree, Cindy 
L Gdnas, William Beaumont Hospital, Royal Oak, MI 
It has been suggested that primary PTCA for AMI is applicable only for a 
small number of experienced, high volume PTCA centers. Between 7/93 and 
1/95, 34 clinical sites in North Amedca, South Amedca, Japan and Europe 
pmspactively enrolled 1100 pts with evolving acute MI into the 2nd Pdmaty 
Angioplasty Myocardial Infarction (PAMi II Study), We determined the impact 
of operator and institutional volume on procedural outcome and hospital 
course. Centers were divided based on overall yearly volume (low < 500, 
medium 501-1000, high > 1000) and operators wore similarly divided (low 
_< 75, medium 76.200, high > 200). AngioplasIy (PTCA) success (< 500 
stenosis with TIMI II or III flow), emergency bypass (CABG) for failed PTCA, 
reinfarotion and mortality rates were determined be~ed on volume. 
Success CABG Reinf~uct> Mortality 
% % % % 
Hospital Volume 
Low 97 0.0 4.1 1.5 
Med 99 0.0 5.7 2.4 
High 98 0.2 5.2 2.1 
P-Value NS NS NS NS 
Operator Volume 
Low 98 0.0 5,5 0.7 
Med 98 0.3 3.7 2.0 
High g8 0.0 6.6 2.8 
P-Value NS NS NS NS 
Conclusion: Primary PTCA for myocardial infarction can be performed in 
a vadety of clinical settings with high success and low complication rates, 
irrespective of operator or institutional volume. 
